Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Descovy (emtricitabine, tenofovir alafenamide) for the Treatment of HIV-1 Infection

Drug (Brand/Generic)

Descovy

Therapy Class

Anti-retroviral

Current Indication

HIV-1 infection

Market Sector

Anti-infective

Development Status

Approved in the US and Europe

Developer

Gilead Sciences
Expand

Go Top